Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Researchers find more selective therapies for cancer

Researchers find more selective therapies for cancer

Research validates Myc inhibition as effective therapeutic strategy for glioma

Research validates Myc inhibition as effective therapeutic strategy for glioma

Novogen declares shareholder meeting results

Novogen declares shareholder meeting results

Identifying epigenetic markers in cancer cells could improve patient treatment

Identifying epigenetic markers in cancer cells could improve patient treatment

Study: Brain tumors hijack the brain's existing blood supply during progression

Study: Brain tumors hijack the brain's existing blood supply during progression

OncoSynergy's OS2966 receives FDA orphan drug designation for treatment of glioblastoma

OncoSynergy's OS2966 receives FDA orphan drug designation for treatment of glioblastoma

Novogen receives funding support to commence studies in muscular dystrophy

Novogen receives funding support to commence studies in muscular dystrophy

Celsion announces financial results for second quarter ended 2014

Celsion announces financial results for second quarter ended 2014

Findings show how galectin-1 protein plays key role in high grade malignant gliomas

Findings show how galectin-1 protein plays key role in high grade malignant gliomas

Induced immunorejection may eliminate tumors post-cell transplantation

Induced immunorejection may eliminate tumors post-cell transplantation

Triple therapy for glioblastoma has prolonged survival of mice with brain cancers

Triple therapy for glioblastoma has prolonged survival of mice with brain cancers

Research helps explain why brain tumors occur more often in males

Research helps explain why brain tumors occur more often in males

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

CCC study provides hope that SapC-DOPS could be used for metastatic brain cancer treatment

CCC study provides hope that SapC-DOPS could be used for metastatic brain cancer treatment

Neurosurgeons develop new technologies to perform highly complex brain surgery

Neurosurgeons develop new technologies to perform highly complex brain surgery

Novocure: 18 physicians certified to prescribe NovoTTF Therapy in Europe and Israel

Novocure: 18 physicians certified to prescribe NovoTTF Therapy in Europe and Israel

Scientists find a new strategy for brain cancer treatment

Scientists find a new strategy for brain cancer treatment

Research finding offers potential therapeutic avenues for glioblastoma

Research finding offers potential therapeutic avenues for glioblastoma

Researchers identify new biomarker that predicts effectiveness of glioblastoma treatment

Researchers identify new biomarker that predicts effectiveness of glioblastoma treatment

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.